Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGM - Nasdaq Real Time Price USD

Relay Therapeutics, Inc. (RLAY)

Compare
2.4700
-0.1500
(-5.73%)
At close: 4:00:00 PM EDT
2.4700
0.00
(0.00%)
After hours: 4:05:06 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
10,007
10,007
25,546
1,381
3,029
Operating Expense
395,681
395,681
404,968
312,333
230,036
Operating Income
-385,674
-385,674
-379,422
-310,952
-227,007
Net Non Operating Interest Income Expense
34,746
34,746
31,045
8,786
830
Other Income Expense
13,220
13,220
6,404
11,657
-137,695
Pretax Income
-337,708
-337,708
-341,973
-290,509
-363,872
Net Income Common Stockholders
-337,708
-337,708
-341,973
-290,509
-363,872
Diluted NI Available to Com Stockholders
-337,708
-337,708
-341,973
-290,509
-363,872
Basic EPS
-2.36
--
-2.79
-2.59
-3.82
Diluted EPS
-2.36
--
-2.79
-2.59
-3.82
Basic Average Shares
142,867.8440
--
122,576.5270
112,233.6490
95,136.7190
Diluted Average Shares
142,867.8440
--
122,576.5270
112,233.6490
95,136.7190
Total Operating Income as Reported
-372,468
-372,468
-373,000
-299,275
-364,698
Total Expenses
395,681
395,681
404,968
312,333
230,036
Net Income from Continuing & Discontinued Operation
-337,708
-337,708
-341,973
-290,509
-363,872
Normalized Income
-350,914
-350,914
-348,395
-302,186
-226,181
Interest Income
34,746
34,746
31,045
8,786
830
Net Interest Income
34,746
34,746
31,045
8,786
830
EBIT
-385,674
-385,674
-379,422
-310,952
-227,007
EBITDA
-380,210
-380,210
-374,153
-306,822
-223,082
Reconciled Depreciation
5,464
5,464
5,269
4,130
3,925
Net Income from Continuing Operation Net Minority Interest
-337,708
-337,708
-341,973
-290,509
-363,872
Total Unusual Items Excluding Goodwill
13,206
13,206
6,422
11,677
-137,691
Total Unusual Items
13,206
13,206
6,422
11,677
-137,691
Normalized EBITDA
-393,416
-393,416
-380,575
-318,499
-85,391
12/31/2021 - 7/16/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

KYMR Kymera Therapeutics, Inc.
25.24
-7.80%
 
ARVN Arvinas, Inc.
7.03
+0.14%
 
RVMD Revolution Medicines, Inc.
33.62
-4.92%
 
TNGX Tango Therapeutics, Inc.
1.2800
-6.57%
 
ITOS iTeos Therapeutics, Inc.
5.63
-5.70%
 
IDYA IDEAYA Biosciences, Inc.
14.77
-9.83%
 
BPMC Blueprint Medicines Corporation
85.94
-2.90%
 
IPSC Century Therapeutics, Inc.
0.4518
-5.08%
 
KURA Kura Oncology, Inc.
6.38
-3.33%
 
OLMA Olema Pharmaceuticals, Inc.
3.3400
-11.17%